In the current study, T2DM model rats exhibited the highest AST/ALT ratio, whereas ALA treatment reduced the AST/ALT ratio, indicating that ALA may reduce the secondary signaling associated with hepatic NLRP3 inflammasome activation in the livers of T2DM model rats. This evidence concerns the gene GPT and type 2 diabetes mellitus.